Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Eldery

This study has been completed.

Sponsor:

Information provided by:

Deutsches Herzzentrum Muenchen

ClinicalTrials.gov Identifier:

NCT00196300

First received: September 13, 2005

Last updated: NA

Last verified: September 2005

History: No changes posted

Purpose

The objective of this study was to determine the prognostic utility of established risk predictors following acute ST elevation myocardial infarction in patients over 75 years of age.

Condition
Myocardial Infarction

Study Type:	Observational
Study Design:	Observational Model: Defined Population Primary Purpose: Screening Time Perspective: Longitudinal Time Perspective: Prospective
Official Title:	Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Eldery

Resource links provided by NLM:

MedlinePlus related topics: Heart Attack

U.S. FDA Resources

Further study details as provided by Deutsches Herzzentrum Muenchen:

Estimated Enrollment:	500
Study Start Date:	January 1995

Eligibility

Ages Eligible for Study:	76 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

acute myocardial infarction; aged >75 years

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00196300

Locations

Germany
Deutsches Herzzentrum Muenchen
Munich, Germany, 80636
1. Medizinische Klinik, Klinikum rechts der Isar
Munich, Germany, 81675

Sponsors and Collaborators

Deutsches Herzzentrum Muenchen

Investigators

Study Chair:	Georg Schmidt, MD	Deutsches Herzzentrum Muenchen
Study Director:	Petra Barthel, MD	Deutsches Herzzentrum Muenchen
Principal Investigator:	Axel Bauer, MD	Deutsches Herzzentrum Muenchen

More Information

Additional Information:

heart rate turbulence home page This link exits the ClinicalTrials.gov site

Publications:

Schmidt G, Malik M, Barthel P, Schneider R, Ulm K, Rolnitzky L, Camm AJ, Bigger JT Jr, Schomig A. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet. 1999 Apr 24;353(9162):1390-6.

Barthel P, Schneider R, Bauer A, Ulm K, Schmitt C, Schomig A, Schmidt G. Risk stratification after acute myocardial infarction by heart rate turbulence. Circulation. 2003 Sep 9;108(10):1221-6. Epub 2003 Aug 25.

Makikallio TH, Barthel P, Schneider R, Bauer A, Tapanainen JM, Tulppo MP, Schmidt G, Huikuri HV. Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era. Eur Heart J. 2005 Apr;26(8):762-9. Epub 2005 Mar 18.

Bauer A, Guzik P, Barthel P, Schneider R, Ulm K, Watanabe MA, Schmidt G. Reduced prognostic power of ventricular late potentials in post-infarction patients of the reperfusion era. Eur Heart J. 2005 Apr;26(8):755-61. Epub 2005 Jan 26.

ClinicalTrials.gov Identifier:	NCT00196300 History of Changes
Other Study ID Numbers:	GE IDE No. R00495
Study First Received:	September 13, 2005
Last Updated:	September 13, 2005
Health Authority:	Germany: Federal Institute for Drugs and Medical Devices

Keywords provided by Deutsches Herzzentrum Muenchen:

Assessment, Risk
Autonomic nervous system
Aged

Additional relevant MeSH terms:

Infarction
Myocardial Infarction
Ischemia
Pathologic Processes
Necrosis

Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on May 23, 2013

To Top